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Abstract
Background: Substantial decline in malaria transmission, morbidity and mortality has been reported in
several countries where new malaria control strategies have been implemented. In Gabon, the national
malaria policy changed in 2003, according to the WHO recommendations. The trend in malaria morbidity
was evaluated among febrile children before and after their implementation in Libreville, the capital city of
Gabon.
Methods: From August 2000 to December 2008, febrile paediatric outpatients and inpatients, under 11
years of age, were screened for malaria by microscopic examination at the Malaria Clinical Research Unit
(MCRU) located in the largest public hospital in Gabon. Climatic data were also collected.
Results: In total, 28,092 febrile children were examined; those under five years always represented more
than 70%. The proportion of malaria-positive slides was 45% in 2000, and declined to 15% in 2008. The
median age of children with a positive blood smear increased from 24(15-48) to 41(21-72) months over
the study period (p < 0.01). Rainfall patterns had no impact on the decline observed throughout the study
period.
Conclusion: The decrease of malaria prevalence among febrile children during the last nine years is
observed following the introduction of new strategies of malaria cases management, and may announce
epidemiological changes. Moreover, preventive measures must be extended to children older than five
years.
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Background
Malaria has, for a long time, been the major cause of
febrile illness in sub-Saharan Africa, where 80% of the
247 million cases were reported in 2006 [1]. The appear-
ance of multidrug-resistance Plasmodium falciparum has
led to the introduction of new control strategies. Insecti-
cide-treated bed nets (ITNs), along with prompt and effec-
tive treatment of clinical malaria cases, intermittent
preventive treatment in pregnant women, and indoor
residual spraying, are now being deployed widely across
Africa with increasing amounts of coverage achieved [2-
4]. There is growing evidence documenting a substantial
decline in malaria transmission, morbidity and mortality
in several countries where these interventions have been
implemented including areas with high levels of transmis-
sion [5-8]. One of the major challenges for the effective
monitoring and evaluation of the impact of malaria con-
trol tools is to provide epidemiological informations in
endemic areas such as Gabon. Throughout this country,
infections with P. falciparum accounted for 30% to 50% of
the consultations of children with fever between 1980s
and 1990s [[9-11], Kombila et al, unpublished data].
Resistance to chloroquine appeared in the 1980s and rose
to 100% since 2001 [12-14]. In 2003, Gabonese Ministry
of Health changed the malaria national policy to follow
the WHO 2000 recommendations [15]. Artemisinin
based combination therapies (ACTs) were adopted as
first- and second-line treatment for uncomplicated
malaria, and along with ITNs and sulfadoxine-pyrimeth-
amine for intermittent preventive treatment (IPTp-SP)
were freely available in all public health centres of country
since 2005, for children under five years old and pregnant
women. Reduced malaria prevalence in pregnant women
was observed in Libreville and Lambaréné following IPTp-
SP implementation [16]. In this study, the trend in
malaria morbidity was evaluated among febrile children,
over a nine-year period, in the largest public hospital of
Libreville, the capital city of Gabon.
Methods
Study site and population
This prospective and observational study was conducted
from August 2000 to December 2008 in Libreville, the
capital city of Gabon, where the climate is equatorial. In
this urban area, malaria is predominantly caused by P. fal-
ciparum. The population of Libreville was estimated to be
537,540 inhabitants in 2006, with children under five
years of age representing 16%.
The Malaria Clinical Research Unit (MCRU) is a branch of
the Department of Parasitology of the Medicine Faculty,
located in the Centre Hospitalier de Libreville (CHL), the
largest public hospital in Gabon. At MCRU, all febrile pae-
diatric outpatients and inpatients, aged less than 11 years
old, were prospectively screened for malaria. In this unit,
children routinely benefit for free malaria diagnosis based
on microscopic examination. Temperature, history of
fever, age, sex, and location were collected prospectively.
Malaria diagnosis
Throughout the study period, a thick blood film was done
for each patient. Blood slides were processed according to
the Lambaréné procedure, which is described elsewhere
[17]. Slides were considered negative if no asexual blood
stages of parasites and gametocytes were seen in 100 oil-
immersion fields. Quality control of the blood smears was
performed: a second microscopist, blinded to the results
of the first reading, read the slides. In case of disagree-
ment, slides were controlled by a third microscopist and
the mean of the two closest readings of parasitaemia was
taken. The case definition of malaria was any febrile child
with slide-confirmed parasites.
Rainfall patterns
Monthly rainfall data of Libreville for the last decade were
obtained from the meteorological services of the Agency
for Air Navigation Safety in Africa and Madagascar
(ASECNA).
Data analysis
Demographic and laboratory data were recorded and
given to the data manager. Data were entered and cleaned
using Epi-info version 3.3.2 (February 9, 2005 CDC
Atlanta) and were analysed with STATA version 10 (Stata
Corp, College station, USA). Medians with interquartile
ranges (IQR) of age and geometric means of parasite den-
sities (GMPD) are presented. Differences between groups
were assessed using Pearson's chi-squared or Fisher's exact
tests for proportions. For ordinal outcomes, the linear
trend test (Cochran-Armitage test for trend) was used. The
association between age and risk of malaria by year was
assessed using odds ratio and the 95% confidence interval
(OR (95%CI)). Linear regression was applied to test the
significance of decreases for log-transformed data. To take
into account the effect of auto-correlated observations
and the season disturbances, an ARMAX model was built
including covariates. We postulated a straightforward
relationship between proportion of malaria cases and the
monthly rainfall average measured by 20-point first-order
moving average that was applied to filter seasonal varia-
tion and highlight the long-term movements in the data.
Deviations in monthly rainfall were examined by compar-
ing monthly values of the parameters (malaria cases, rain-
fall, time series data) obtained during the study period (9
years).
The significance level of all comparison was set at 0.05. All
reported p-values are two-tailed.Malaria Journal 2009, 8:300 http://www.malariajournal.com/content/8/1/300
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Results
Prevalence of febrile cases
During the nine-year study period, slides from 28,092
febrile children were examined at the MCRU. The number
of children screened showed two peaks, in 2002 (n =
4867) and in 2008 (n = 4684). There was a decrease in the
yearly number of consultations for fever from 2002 to
2005, followed by a significant increase until 2008 (p <
0.01, Cochran-Armitage test for trend) (Table 1).
The median (IQR) age of children consulting for fever was
globally of 24(12-48) months. This did not significantly
change from one year to another over the nine years
(Table 1). Overall, children younger than five years repre-
sented 76% of the screened patients; this proportion was
nearly the same over the surveillance period (Table 1).
More than 55% of the febrile patients screened each year
at MCRU were aged 0 to 35 months.
Malaria prevalence
There was a linear decrease in the annual number of
malaria cases, from 1,785 in 2002 to 359 in 2007 with a
slight increase in 2008 (p < 0.01, Cochran-Armitage test
for trend). In 2000, the proportion of febrile illness due to
malaria was 45%; this proportion declined to 12% in
2007 and 15% in 2008.
Age and malaria
The median (IQR) age of children with a positive blood
smear significantly increased from 24(15-48) to 41(21-
72) months over the study period (p < 0.01). In 2000, par-
asite prevalence was highest and the median age of
patients with positive slides the lowest (Figure 1). The
median age of patients with malaria negative slides did
not fluctuate (24(12-48)) over the time. The lowest prev-
alence of malaria throughout the study period was found
among the 0-23 months old patients (Figure 2). The pro-
portion of malaria cases in the febrile children increased
with age until 47 months (p < 0.01, Cochran-Armitage test
for trend); from four years old, the proportion of malaria
cases was similar in the different age groups (Figure 2).
The study population was grouped into those less than
five years and the oldest (Table 1). In children younger
than five years old, the prevalence of malaria decreased
significantly in 2001 (26%), compared to the year 2000 (p
< 0.01). A relative increase in malaria cases of 10% was
observed between 2001 and 2002, followed by a drop of
about two third in 2007 (10%) and 2008 (13%) (p < 0.01,
Cochran-Armitage test for trend). In older children (5-10
years), the proportion of malaria cases was significantly
higher compared to the youngest; the risk of having
malaria was 1.2 to 2.0 in older patients than younger ones
(Table 1).
According to the paediatric ward, data were compared
between inpatients group (n = 15299) and outpatients
group (n = 7502); origin was not known for 5291 chil-
dren. Between 2000 and 2005, the proportion of malaria
cases among children aged less than 24 months was
always higher in the inpatients group (25-35%) compared
to the outpatients (11-23%) (p < 0.01). From 2006, the
same difference was only observed for patients aged 96 to
120 months old ((p < 0.02). During the study period, the
median age did not significantly vary among the infected
inpatients, ranging from 18 to 24 months old; whereas in
the infected outpatients group, it ranged from 21 to 40
months (p < 0.01)
Parasite densities
Parasitaemia ranged from 14/μL to 1,611,408/μL. The
GMPD did not vary significantly over the study period,
and ranged from 6,800 p/μL in 2000 to 7,512 p/μL in
2008. Depending on the age, the GMPD was slightly
higher in children less than five years old (6751/μL to
9,779/μL) than in children aged 5-10 years old (3,593/μL
to 6,951/μL). No difference was observed when compar-
Table 1: Proportion of malaria cases according to age (between 2000 to 2008)
2000 2001 2002 2003 2004 2005 2006 2007 2008
Number of children 889 3525 4867 4133 2932 1174 2172 3116 4684
Age, Median(IQR)a, months 24(13-48) 24(12-48) 24(13-54) 24(12-48) 24(12-54) 24(12-48) 24(12-48) 24(12-60) 24(12-48)
Proportion with Malaria 45% 27% 36.7% 36.4% 30.0% 24.5% 21.0% 12.0% 15.0%
Children (0- <5 years), N(%) 699 (79%) 2795 (79%) 3656 (75%) 3159 (76%) 2190 (75%) 1347 (75%) 1655 (76%) 2327 (75%) 3630 (78%)
-proportion with malaria 45% 26% 36% 34% 28% 21% 19% 10% 13%
Children (5-10 years), N,(%) 190 (21%) 730 (22%) 1211 (25%) 974 (24%) 742 (25%) 427 (25%) 517 (24%) 789 (25%) 1054 (23%)
- proportion with malaria 46% 31% 40% 43% 37% 35% 27% 16% 23%
OR (95%CI)b for malaria risk
- children 
(0 - <5  years)
Reference Reference Reference Reference Reference Reference Reference Reference Reference
- children 
(5-10 years)
1.0 (0.7-1.4) 1.3 (1.1-1.5) 1.2 (1.1-1.3) 1.5 (1.3-1.7) 1.6 (1.3-1.8) 2.0 (1.6-2.6) 1.5 (1.2-1.9) 1.7 (1.4-2.2) 2.0 (1.6-2.3)
p-value 0.91 0.004 0.02 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
a: interquartile ranges (25th and 75th percentiles); b: Children less than five years served as reference; N: numberMalaria Journal 2009, 8:300 http://www.malariajournal.com/content/8/1/300
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ing GMPD between inpatient and outpatient groups
(results not shown).
Rainfall and malaria prevalence
Rainfall patterns were similar throughout the study
period. June, July and August were the driest months with
recorded rainfalls of 0 to 85 mm, except for the years 2000
and 2006 (Figure 3). The rest of the months were gener-
ally rainy with the wettest period from October to Decem-
ber (330-400 mm).
Monthly malaria prevalence data showed that there was a
slight decrease in the proportion of positive slides from
February to May, with a continuous increase between May
and October (Figure 3). However, a comparison of the
proportions of malaria cases during the rainy (mean prev-
alence obtained between September and May) and the dry
season (mean prevalence obtained between June and
August) did not show any difference over the study
period. Indeed, analysis of time series auto-correlation on
de-seasonalized data showed that there was an absence of
correlation between means of monthly rainfall, with an
autocorrelation coefficient of 0.48 (95%CI: -1.81-0.86)
(standard error 0.68) (p = 0.48). Rainfall had no effect on
the intercept of the trends in the proportion of malaria
cases observed during the study period (Table 2).
Discussion
Understanding the local epidemiology of malaria is essen-
tial to design the best methods to control the disease. This
prospective study assessed the evolution of malaria mor-
bidity in an urban hospital care seeking febrile children of
Gabon, and showed that the pattern of P. falciparum infec-
tion has changed from 2000 to 2008. The proportion of
malaria positive slides among febrile children seen at hos-
pital strongly declined and was accompanied by a rise in
the age of children with malaria. This follows a twenty-
year period during which the prevalence of malaria was
29% in 1980, and had increased to more than 40% in
2000 [18]. The evolution of the proportion of malaria
cases, diagnosed using the same standardized method,
did not follow the yearly recorded number of febrile
patients; whatever the number of children seen at MCRU,
the number of malaria cases consistently decreased over
the time. The fact that the proportion of non malaria cases
significantly rose during the study period while a signifi-
cant downward trends in malaria cases was observed, sug-
gests that this decline is specific to malaria.
The decrease in the prevalence of malaria started in 2001,
probably due to several factors. Climatic data were ana-
lysed; rainfall patterns remained constant throughout the
nine years of observation and had no impact on the dras-
PBS: proportion of malaria positive blood smears Figure 1
PBS: proportion of malaria positive blood smears.
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tic reduction in malaria cases. The proportion of malaria
positive blood smears did not show any seasonal varia-
tion. Numerous interventions occurred in the country
during the study period. Indeed, at the beginning of the
study, chloroquine was the first line and the main treat-
ment for mild malaria, despite a well documented resist-
ance above 90% [13,14]. Consecutively, a change in
malaria treatment behaviour was observed; between 2000
and 2006, artemisinin derivatives based monotherapies
and artemether-lumefantrine combination (from 2002),
that were widely available in the country, became the
most frequently antimalarials prescribed. In 2003, artesu-
nate-amodiaquine and artemether-lumefantrine were
chosen as first and second line treatments for uncompli-
cated malaria [15]. This policy decision, supported by the
Global Fund, led to the deployment of free distribution of
ACTs and ITNs in 2005 in public health facilities, target-
ing children younger than five years old. Bednet impreg-
Age distribution of the proportion of malaria cases by year among children under 11 years (from 2000 to 2008) Figure 2
Age distribution of the proportion of malaria cases by year among children under 11 years (from 2000 to 
2008).
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Monthly distribution of the proportion of malaria positive blood smears and mean rainfall Figure 3
Monthly distribution of the proportion of malaria positive blood smears and mean rainfall.
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nation campaigns began at the same time. ITNs coverage
reached 49.8% in 2006 and 57% in 2008 [[1], Malaria
control program, unpublished data]. More than two mil-
lions of ACTs packs have been distributed in public health
centres from 2006 to 2008. This can be surprising when
considering that the target population comprised 272,000
children less than five years; but presumptive treatment of
fever with an antimalarial drug is still frequent in Gabon,
and ACTs are freely provided to the patients, irrespective
of their age [19].
The good efficacy of artemisinin derivatives based thera-
pies, which was evaluated to be higher than 95% in 2005,
and the use of ITNs may have contributed, independently
or in association, to the reduction of the morbidity of the
disease as demonstrated elsewhere [8,20-23].
Throughout the nine-year study period, the burden of
febrile illness remained highest among children under
five years old. However, the median age of children with
malaria significantly increased, as the prevalence of the
infection declined. From 2001, children over five years of
age were more likely to have malaria, suggesting a higher
exposure (though that most of them do not benefit from
free ITNs in Libreville) or a delayed acquisition of immu-
nity, as observed by other authors [24-27]. However, this
changing age pattern was not observed in the inpatient
group, then, the severity of the disease remained confined
to the youngest as reported elsewhere [3,6,28].
The decline of malaria prevalence and the age shift
towards the older children may indicate a change in the
dynamics of malaria epidemiology in Libreville. It has
been reported that the age at which patients experience
malaria increases with a decline in exposure, and may pre-
cede changes in malaria transmission [3,7,25]. Further-
more, urbanization is extending in Libreville, creating a
hostile environment to anophelinae vector development.
This study was a health facility-based survey, probably not
representative of the situation in the entire country; in sev-
eral private health centres and rural areas, laboratory and/
or well-trained microscopists are lacking. Moreover, the
function of the MCRU in the CHL is to provide results of
freely available microscopic diagnosis of malaria to clini-
cians working in the different wards, information on
malaria clinical presentations, outcomes and treatments
are missing.
Conclusion
The proportion of malaria among febrile children has
decreased during the last nine years, probably due to the
impact of the utilization of more effective antimalarial
drugs, artemisinin derivatives based therapies. After the
wide-scale introduction of new effective prevention and
disease management strategies, this decline was more pro-
nounced. All these interventions are likely to be the main
possible contributing factors to the observed malaria
changes. Preventive measures must be further imple-
mented and extended to older children. Studies on the
prevalence of malaria in other parts of the country and
record of entomological data are needed to characterize
the transmission levels in Gabon.
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